Abstract We report a case in which motor cortex stimulation (MCS) improved neuropathic facial pain due to peripheral nerve injury and restored tactile and thermal sensory loss. A 66-year-old man developed intractable trigeminal neuropathic pain after trauma of the supraorbital branch of the Vth nerve, associated with tactile and thermal sensory loss in the painful area. MCS was performed using neuronavigation and transdural electric stimulation to localize the upper facial area on the motor cortex. One month after surgery, pain was decreased from 80/100 to 20/ 100 on visual analogic scale, and sensory discrimination improved in the painful area. Two months after surgery, quantitative sensory testing confirmed the normalization of thermal detection thresholds. This case showed that MCS could restore tactile and thermal sensory loss, resulting from peripheral nerve injury. Although the mechanisms leading to this effect remain unclear, this observation enhanced the hypothesis that MCS acts through modulation of the sensory processing.
Introduction
Motor cortical stimulation (MCS) has been proposed to treat intractable chronic central and peripheral neuropathic pain [1, 2] . The mechanisms underlying the pain control remain unclear. MCS can improve dysesthesias and allodynia in the painful area [3] , but only few patients reported sensory changes after MCS [4] with lack of details concerning the delay of improvement in these patients. We report the case of a patient with post-traumatic peripheral neuropathic pain of the scalp in which MCS rapidly alleviated pain and sensory impairment, enhancing the hypothesis of modulation of the sensory processing.
Case report
A 66-year-old man had a cranial trauma in March 2004 with a wound of the right supra-orbital branch of the ophthalmic nerve (V1) inducing severe hypoesthesia of the anterior scalp. After 2 months, intense paroxysmal attacks of pain appeared in the area of sensory loss. The pain was precipitated from a trigger area located on right side of the bridge of the nose, not affected by the sensory loss. Progressively, intensity and frequency of painful paroxysms increased, and a lancinating constant pain developed. Initial treatment consisted in monotherapy with amitriptyline (rapidly stopped because of sedative effects) and various anti-epileptic drugs (gabapentin 2,400 mg, carbamazepine 1,200 mg, oxcarbazepine 600 mg). Association of gabapentin and oxcarbazepine partially reduced the pain intensity. A first block of the supra-orbital branch of the ophthalmic nerve, using an association of local anesthetics and long-lasting steroids, partially alleviated the pain during 1 month. Two additional nerve blocks failed to confirm this initial improvement. Conventional trans-cutaneous electrical stimulation had no effect. As the pain became therapy-resistant, the patient was referred in August 2006 to discuss MCS.
Preoperative assessment showed a tactile and thermal sensory loss in the supra-orbital V1 territory (Fig. 1) . The sensory thresholds for innocuous and noxious thermal stimulation were measured in the painful area by TSA 2001 apparatus (Medoc), using a Peltier device, according to previously described protocol [5] , in comparison with the corresponding area on the uninjured side (Fig. 2) . The tactile sensory loss was confirmed by the use of sensory testing monofilament (5.07/10 g filament). Pain was scored 80/100 on visual analogic scale (VAS). Patient assessment using HAD scale showed an emotional impact concerning anxious dimension but not depressive dimension (anxiety score = 10, depression score = 4).
Two quadripolar electrodes (Resume, Medtronic) were implanted epidurally over the left central sulcus over the area corresponding somatotopically to the right upper face, localized using MRI-based neuronavigation. After craniotomy, two parallel electrodes were placed just above the area where transdural electrical stimulation induced motor responses in the contralateral cheek. Electrodes were then connected to an internal generator (Synergy, Medtronic). The parameters used for chronic bipolar stimulation were: frequency 40 Hz, amplitude 3 V and pulse width 210 ms.
From the third post-operative day, the pain has sharply declined. One month after surgery, it was quoted 20/100 on the VAS. This pain relief concerned both paroxysmal and constant pain. Moreover, the trigger area had disappeared. Oxcarbazepine dose was stopped. Gabapentin was decreased to 600 mg per day but could not be stopped.
One month after surgery, the patient reported that sensory disturbances had improved, concerning both tactile and thermal sensitivity. Two months after surgery, sensory testing monofilament and quantitative thermal assessment confirmed this subjective impression. Previously impaired thermal detection thresholds were normalized (Fig. 2,  lower panel) . Eighteen months after surgery the effect on pain and sensitivity remained the same.
Discussion
This case shows that sensory loss, resulting from peripheral nerve injury, has been reversed by MCS, early after surgery. Improvement of sensory loss in the painful zone after MCS has been previously reported in the literature [4, 5] . In one series, post-operative improvement of facial sensory discrimination was mentioned but not quantified in three patients, suffering from post-therapeutic neuralgia, geniculate neuralgia and post-stroke central pain [4] . Drouot et al. [5] reported improvement of thermal sensory thresholds by switching ''on'' MCS, in 8 of 18 patients having altered thermal sensory thresholds in the painful area. Changes in vibratory sensory thresholds were not significant. However, in this series, thermal changes were evaluated between 6 and 18 months after surgery without comparison with pre-operative status. These thermal sensory changes induced by MCS may be similar to those induced by repetitive transcranial magnetic stimulation (rTMS) [6, 7] . RTMS has been shown to be efficient to treat neuropathic chronic pain and probably shares with MCS several of its mechanisms of action [8, 9] . However, the thermal sensory changes induced by rTMS were the opposite of those induced by MCS [8] . The present case is the first reported one in which thermal sensory changes are documented before and after surgery. Moreover, pain and sensory loss was clearly related to a peripheral nerve injury. The mechanisms leading to sensory restoration remain difficult to explain. Considering that nerve injury reduces the afferent input, the MCS improvement of sensory thresholds is quite surprising. It is very unlikely that MCS could enhance nerve growth to lead so quickly to sensory restoration, more than 2 years after initial injury. MCS could have acted by favoring plasticity and reorganization of the sensory cortex, but functional imaging studies have failed to demonstrate any activation of the somato-sensory cortex during or after MCS [10] . One hypothesis could be that the sensory impairment, initially due to the peripheral nerve injury, has been secondary maintained by central mechanisms, and that these central mechanisms have been reversed by MCS, leading to the sensory restoration. Deafferentation-induced neuronal hyperactivity [11] and reorganization of the sensory maps [12] in the thalamus are thought to disturb the control exerted by non-nociceptive sensory afferents on pain pathways and then contributing to the occurrence of neuropathic pain [13] . Drouot et al. [5] reported that pain was not reduced by MCS in patients in whom thermal sensory thresholds were not modified by switching ''on'' the MCS. MCS could both relieve pain and improve sensory loss through changes in the altered thalamic sensory maps and/or by decreasing the thalamic neuronal hyperactivity [1, 14] interfering with sensory processing.
Conclusion
This case showed that MCS could restore tactile and thermal sensory loss resulting from peripheral nerve injury. Although the mechanisms leading to this effect remain unclear, this observation enhanced the hypothesis that MCS acts through modulation of the sensory processing. This observation has to be confirmed by systematic preand post-operative sensory testing with objective measurement of nerve function (e.g., blink reflex).
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